# Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.

> **NCT04595734** · — · UNKNOWN · sponsor: **Western Sydney Local Health District** · enrollment: 500 (estimated)

## Conditions studied

- Lung Cancer Stage IV
- Lung Cancer, Non-small Cell
- Hepatitis

## Interventions

- **OTHER:** No intervention due to observational methods of study

## Key facts

- **NCT ID:** NCT04595734
- **Lead sponsor:** Western Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-07
- **Primary completion:** 2023-01-10
- **Final completion:** 2025-01-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595734, "Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04595734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*